Tag: PAXLOVID

Pfizer gets PAXLOVID FDA approval for COVID-19 in high-risk adults

businessnewstoday- May 25, 2023

Pfizer has obtained approval for PAXLOVID, an oral combination therapy of nirmatrelvir tablets and ritonavir tablets, from the US Food and Drug Administration (FDA) to ... Read More

Torrent Pharmaceuticals gets rights to generic of Pfizer’s oral Covid-19 treatment

pallavi123- March 18, 2022

Torrent Pharmaceuticals has entered into a licensing agreement with Medicine Patent Pool (MPP) for manufacturing and commercializing the generic version of Pfizer’s oral Covid-19 treatment. ... Read More

SMS Pharmaceuticals gets license to Pfizer Covid‐19 drug nirmatrelvir

pallavi123- March 17, 2022

SMS Pharmaceuticals has secured a non‐exclusive license via the Medicines Patent Pool (MPP) for manufacturing nirmatrelvir, an oral antiviral Covid‐19 drug developed by Pfizer, to ... Read More